Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet Luciano Artur Lopes Pereira; Catarina Meng; Manuel Augusto Gonçalves Amoedo; Maria Teresa de Sousa Costa Pinto Ferreira Mendes; Marco Alexandre Mateus Prazeres Marques; João Miguel Machado Dória Frazão; André Luiz Loureiro Weigert;

External validation of a predictive model for one-year mortality in incident hemodialysis patients: A Portuguese cohort Telma Pais; Beatriz Teixeira; Miguel Carrilho; José Agapito Fonseca; Cristina Outerelo; Sofia Jorge; Cristina Resina; José António Lopes; Joana Gameiro;

Activation and disease control of patients on chronic hemodialysis: An observational study Sara Ramírez-Sánchez; María Jesús Soriano-Munuera; Elena Lucia Gras-Colomer; Alicia Cana-Poyatos; Teresa García-Martínez; Rafael Ortiz-Ramon; Sara Linares-Aguayo; Alicia García-Testal;